Stock report · Delisted · Nasdaq
Sensei Biotherapeutics Inc (SNSE)
25.96USD Delisted Final close · Jul 17, 2026
SNSE no longer trades. Sensei Biotherapeutics was delisted from the Nasdaq in July 2026.
All prices on this page are historical. The last trade was on July 17, 2026, at $25.96.
SNSE stock price history
Final trading statistics
- Final close
- $25.96
- Final trading day
- Jul 17, 2026
- Market cap at delisting
- $34.84M
- Shares outstanding
- 1.34M
- Final 52-week range
- $6.33 – $36.93
- Avg. volume (final 3 mo.)
- 65,417
- All-time high
- $455.00 · Feb 2021
- All-time low
- $5.78 · Apr 2025
- Return since IPO
- -93.1%
- Beta
- -0.23
- Book value / share
- −$102.43
- Price / book
- -0.25
About Sensei Biotherapeutics Inc
Sensei Biotherapeutics, Inc. was a clinical-stage biotech company discovering and developing cancer treatments. PIKTOR, an investigational inhibitor acting on several points of the PI3K/AKT/mTOR pathway, was being developed for endometrial and breast cancer.
Solnerstotug, a monoclonal antibody aimed at the VISTA immune checkpoint, was in a Phase 1/2 trial for solid tumors. Early-stage antibodies SNS-102 and SNS-103 also targeted solid tumors, and SNS-201 was a bispecific antibody targeting CD28.
Formerly Panacea Pharmaceuticals, Inc., the company was incorporated in 1999 and based in Rockville, Maryland. It was delisted from the Nasdaq in July 2026, last trading on July 17, 2026 at $25.96.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Rockville, MD
- Employees
- 29
- IPO date
- February 4, 2021
- Delisted
- July 17, 2026
- SEC CIK
- 1829802
Sensei Biotherapeutics financials before the delisting
The last 5 fiscal years Sensei Biotherapeutics reported as a public company, fiscal year ending December.
SNSE revenue and net income
SNSE earnings per share
SNSE annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $0.00 | −$21.1M | −$11.54 |
| FY2024 | $0.00 | −$30.2M | −$1.16 |
| FY2023 | $0.00 | −$34.1M | −$1.22 |
| FY2022 | $0.00 | −$48.8M | −$1.58 |
| FY2021 | $0.00 | −$36.8M | −$1.36 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Sensei Biotherapeutics stock FAQ
What happened to Sensei Biotherapeutics stock?
Sensei Biotherapeutics was delisted from the Nasdaq in July 2026. The final close was $25.96 on July 17, 2026.
Can I still buy SNSE stock?
No. SNSE is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on July 17, 2026.
What was the last price of SNSE?
SNSE last closed at $25.96 on July 17, 2026, which valued the company at about $34.84M.
How did Sensei Biotherapeutics do in its last full fiscal year?
In fiscal 2025, its last full year as a public company, Sensei Biotherapeutics reported revenue of $0.00 and net income of −$21.1M.
When did Sensei Biotherapeutics go public?
Sensei Biotherapeutics shares started trading on February 4, 2021.
SNSE no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.